Kaposi’s Sarcoma-Associated Herpesvirus ori-Lyt -Dependent DNA Replication: Involvement of Host Cellular Factors (cid:1)
暂无分享,去创建一个
[1] Yan Wang,et al. Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: DualRole of Replication and Transcription Activator , 2006, Journal of Virology.
[2] S. Chattopadhyay,et al. The two helicases of herpes simplex virus type 1 (HSV-1). , 2006, Frontiers in bioscience : a journal and virtual library.
[3] T. Shenk,et al. Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Venkitaraman,et al. Initiation of DNA Replication Requires the RECQL4 Protein Mutated in Rothmund-Thomson Syndrome , 2005, Cell.
[5] C. Lilley,et al. DNA repair proteins affect the lifecycle of herpes simplex virus 1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] Yan Wang,et al. Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription , 2004, Journal of Virology.
[7] A. Baiker,et al. Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Knipe,et al. Proteomics of Herpes Simplex Virus Replication Compartments: Association of Cellular DNA Replication, Repair, Recombination, and Chromatin Remodeling Proteinswith ICP8 , 2004, Journal of Virology.
[9] D. Aucoin,et al. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). , 2004, Virology.
[10] D. Ganem,et al. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.
[11] H. Heng,et al. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics , 2004, Chromosome Research.
[12] I. Hickson,et al. RecQ helicases: suppressors of tumorigenesis and premature aging. , 2003, The Biochemical journal.
[13] Yunmei Ma,et al. Mechanism and regulation of human non-homologous DNA end-joining , 2003, Nature Reviews Molecular Cell Biology.
[14] Frederick Y. Wu,et al. Cell Cycle Arrest by Kaposi's Sarcoma-Associated Herpesvirus Replication-Associated Protein Is Mediated at both the Transcriptional and Posttranslational Levels by Binding to CCAAT/Enhancer-Binding Protein α and p21CIP-1 , 2003, Journal of Virology.
[15] Stephen C. West,et al. Molecular views of recombination proteins and their control , 2003, Nature Reviews Molecular Cell Biology.
[16] Yan Wang,et al. Kaposi's Sarcoma-Associated Herpesvirus Lytic Origin (ori-Lyt)-Dependent DNA Replication: Identification of the ori-Lyt and Association of K8 bZip Protein with the Origin , 2003, Journal of Virology.
[17] R. Roeder,et al. Principal Role of TRAP/Mediator and SWI/SNF Complexes in Kaposi's Sarcoma-Associated Herpesvirus RTA-Mediated Lytic Reactivation , 2003, Molecular and Cellular Biology.
[18] S. Weller,et al. Helicase Motif Ia Is Involved in Single-Strand DNA-Binding and Helicase Activities of the Herpes Simplex Virus Type 1 Origin-Binding Protein, UL9 , 2003, Journal of Virology.
[19] I. Lehman,et al. Origin-specific unwinding of herpes simplex virus 1 DNA by the viral UL9 and ICP8 proteins: Visualization of a specific preunwinding complex , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Aucoin,et al. Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Contains Two Functional Lytic Origins of DNA Replication , 2002, Journal of Virology.
[21] A. Bürkle. Physiology and pathophysiology of poly(ADP‐ribosyl)ation * , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] S. Weller,et al. Residues within the Conserved Helicase Motifs of UL9, the Origin-binding Protein of Herpes Simplex Virus-1, Are Essential for Helicase Activity but Not for Dimerization or Origin Binding Activity* , 2001, The Journal of Biological Chemistry.
[23] Won-Jong Jang,et al. Origin-Independent Assembly of Kaposi's Sarcoma-Associated Herpesvirus DNA Replication Compartments in Transient Cotransfection Assays and Association with the ORF-K8 Protein and Cellular PML , 2001, Journal of Virology.
[24] Peter Ghazal,et al. Annexation of the interchromosomal space during viral infection , 2000, Nature Cell Biology.
[25] R. Liskay,et al. Mammalian DNA mismatch repair. , 1999, Annual review of genetics.
[26] R. Sun,et al. Kinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression , 1999, Journal of Virology.
[27] T. Schulz,et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 1998, The Journal of general virology.
[28] M. Ratain,et al. Topoisomerase I Inhibitors. , 1997, The oncologist.
[29] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[30] D. Ganem. Human herpesvirus 8 and the biology of Kaposi's sarcoma , 1996 .
[31] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[33] G. Hayward,et al. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays , 1995, Journal of virology.
[34] M. Kawanishi. Topoisomerase I and II activities are required for Epstein-Barr virus replication. , 1993, The Journal of general virology.
[35] I. Lehman,et al. The herpes simplex virus type-1 origin binding protein. DNA helicase activity. , 1993, The Journal of biological chemistry.
[36] G. Hayward,et al. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt , 1992, Journal of virology.
[37] A. Dalgleish,et al. Kaposi's sarcoma. , 1991, British Journal of Cancer.
[38] M. Muller,et al. Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent , 1990, Journal of virology.
[39] J. D. Benson,et al. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome , 1988, Journal of virology.
[40] R. Knippers,et al. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks , 1988, Molecular and cellular biology.
[41] D. McGeoch,et al. Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis , 1988, Journal of virology.
[42] U. Strausfeld,et al. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo. , 1987, Nucleic acids research.